Skip to content

Revi Life Sciences

3 viewers · 30d

Total raised

$340K

2 filings since 2024 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $340K
ROUNDS
2
INVESTORS
9
FOUNDED
2023
HQ
Austin, TX
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Revi Life Sciences, Inc. is a biotechnology-centric company specializing in innovative solutions that enhance the understanding and modeling of human vascular physiology. Their primary focus is on developing in-vitro models that replicate human vascular systems through engineered micro-environments, facilitating advanced research and development within the life sciences sector.

What sets it apart

Revi Life Sciences stands out by utilizing real human tissues in their models, significantly improving the fidelity of studies related to human vascular biology compared to traditional methods.

Funding history

2 rounds
SAFEJan 22, 2025
Form D/A
+$340K$340K total
SAFEJan 23, 2024
Form D
+$40K total

Products

1 tracked

In-Vitro Vascular Models

Biomedical Research

Revi Life Sciences offers a comprehensive suite of in-vitro vascular models designed to accurately simulate human vascular physiology. These models are engineered to reflect the complex interactions present in human vascular systems using real human tissues, resulting in highly relevant biological representations for research.

  • Use of real human tissues
  • Engineered micro-environments
  • High fidelity replication of human vascular systems
  • Applications in drug discovery and disease modeling